Table V.
Genotype and allele frequencies of five SNPs of APOBEC3H.
A, Rs56695217 genotype and allele | |||||||||
---|---|---|---|---|---|---|---|---|---|
CHB patients (n=104) | LC patients (n=265) | HCC patients (n=287) | |||||||
SNP | N (%) | OR (95%Cl) | P-valuea | N (%) | OR (95%Cl) | P-valueb | N (%) | OR (95%Cl) | P-valuec |
Number detected | n=89 | n=235 | n=241 | ||||||
CC | 11 (12.4) | 1 | 29 (12.3) | 26 (10.8) | |||||
CG | 76 (85.4) | 1.03 (0.49,2.17) | 0.94 | 203 (86.4) | 1.26 (0.71,2.25) | 0.43 | 214 (88.8) | 1.17 (0.54,2.56) | 0.69 |
GG | 2 (2.2) | 0.60 (0.09,4.13) | 0.60 | 3 (1.3) | 0.34 (0.03,3.64) | 0.36 | 1 (0.4) | 0.11 (0.01,1.37) | 0.08 |
CG+GG | 78 | 1.02 (0.48,2.15) | 0.96 | 206 | 1.25 (0.70,2.22) | 0.45 | 215 | 1.14 (0.53,2.47) | 0.74 |
C Allele | 98 (55.1) | 1 | 261 (55.5) | 1 | 266 (55.2) | 1 | |||
G Allele | 80 (44.9) | 0.98 (0.69,1.39) | 0.91 | 209 (44.5) | 0.99 (0.76,1.27) | 0.92 | 216 (44.8) | 1.00 (0.71,1.42) | 0.98 |
B, Rs139292 genotype and allele | |||||||||
CHB patients (n=104) | LC patients (n=265) | HCC patients (n=287) | |||||||
SNP | N (%) | OR (95%Cl) | P-valuea | N (%) | OR (95%Cl) | P-valueb | N (%) | OR (95%Cl) | P-valuec |
Number detected | n=95 | n=247 | n=250 | ||||||
DEL | 42 (44.2) | 1 | 111 (44.9) | 1 | 112 (44.8) | 1 | |||
CAA.DEL | 53 (55.8) | 0.97 (0.60,1.57) | 0.90 | 134 (54.3) | 1.04 (0.72,1.49) | 0.84 | 137 (54.8) | 1.03 (0.91,0.63) | 0.91 |
CAA | 0 (0.0) | 0.73 (0.66,0.80) | 1.00 | 2 (0.8) | 0.50 (0.60,7.09) | 0.68 | 1 (0.4) | 0.73 (0.66,0.80) | 1.00 |
DEL+CAA | 53 | 0.99 (0.61,1.60) | 0.95 | 136 | 1.03 (0.72,1.48) | 0.86 | 138 | 1.03 (0.63,1.69) | 0.89 |
DEL Allele | 137 (72.1) | 1 | 356 (72.1) | 1 | 361 (72.2) | 1 | |||
CAA Allele | 53 (27.9) | 0.69 (1.00,1.46) | 1.00 | 138 (27.9) | 0.99 (0.75,1.31) | 1.00 | 139 (27.8) | 0.99 (0.69,1.45) | 1.00 |
C, Rs139297 genotype and allele | |||||||||
CHB patients (n=104) | LC patients (n=265) | HCC patients (n=287) | |||||||
SNP | N (%) | OR (95%Cl) | P-valuea | N (%) | OR (95%Cl) | P-valueb | N (%) | OR (95%Cl) | P-valuec |
Number detected | n=102 | n=263 | n=280 | ||||||
CC | 41 (40.2) | 1 | 115 (43.7) | 1 | 118 (42.1) | 1 | |||
CG | 16 (15.7) | 0.84 (0.42,1.68) | 0.63 | 38 (14.4) | 0.95 (056,1.62) | 0.85 | 36 (12.9) | 0.85 (0.42,1.72) | 0.65 |
GG | 45 (44.1) | 0.87 (0.52,1.44) | 0.58 | 110 (41.8) | 1.78 (0.81,1.70) | 0.39 | 126 (45.0) | 1.07 (0.64,1.79) | 0.79 |
CG+GG | 61 | 0.86 (0.54,1.38) | 0.53 | 143 | 1.12 (0.79,1.58) | 0.53 | 174 | 1.01 (0.63,1.63) | 0.97 |
C Allele | 98 (49.4) | 1 | 268 (49.8) | 272 (77.0) | 1 | ||||
G Allele | 106 (50.6) | 0.89 (0.64,1.23) | 0.48 | 258 (50.2) | 1.15 (0.89,1.48) | 0.28 | 288 (23.0) | 0.98 (0.71,1.35) | 0.90 |
D, Rs139302 genotype and allele | |||||||||
CHB patients (n=104) | LC patients (n=265) | HCC patients (n=287) | |||||||
SNP | N (%) | OR (95%Cl) | P-valuea | N (%) | OR (95%Cl) | P-valueb | N (%) | OR (95%Cl) | P-valuec |
Number detected | n=89 | n=229 | n=255 | ||||||
CC | 34 (38.2) | 1 | 86 (37.6) | 1 | 81 (31.8) | 1 | |||
CG | 20 (22.5) | 1.1 (0.57,2.11) | 0.79 | 56 (24.5) | 1.38 (0.86,2.20) | 0.18 | 74 (29.0) | 1.53 (0.80,2.94) | 0.20 |
GG | 35 (39.3) | 0.98 (0.55,1.72) | 0.93 | 87 (30.8) | 1.25 (0.82,1.91) | 0.30 | 100 (39.2) | 1.31 (0.73,2.33) | 0.37 |
CG+GG | 55 | 1.02 (0.61,1.70) | 0.94 | 143 | 1.30 (0.89,1.90) | 0.18 | 174 | 1.39 (0.83,2.24) | 0.21 |
C Allele | 88 (49.4) | 1 | 228 (49.8) | 1 | 236 (46.3) | 1 | |||
G Allele | 90 (50.6) | 0.99 (0.70,1.40) | 0.94 | 230 (50.2) | 0.87 (0.68,1.12) | 0.28 | 274 (53.7) | 0.88 (0.63,1.24) | 0.47 |
E, Rs139316 genotype and allele | |||||||||
CHB patients (n=104) | LC patients (n=265) | HCC patients (n=287) | |||||||
SNP | N (%) | OR (95%Cl) | P-valuea | N (%) | OR (95%Cl) | P-valueb | N (%) | OR (95%Cl) | P-valuec |
Number detected | n=103 | n=263 | n=281 | ||||||
CC | 17 (16.5) | 1 | 43 (16.3) | 1 | 37 (13.2) | 1 | |||
CT | 46 (44.7) | 1.02 (0.52,1.97) | 0.96 | 117 (44.5) | 0.26 (0.75,2.10) | 0.39 | 133 (47.3) | 1.36 (0.69,2.69) | 0.38 |
TT | 40 (38.8) | 1.01 (0.51,2.00) | 0.97 | 103 (39.2) | 1.24 (0.73,2.10) | 0.42 | 111 (39.5) | 1.40 (0.69,2.77) | 0.37 |
CT+TT | 86 | 1.01 (0.54,1.89) | 0.97 | 220 | 1.25 (0.77,2.03) | 0.37 | 244 | 1.37 (0.72,2.60) | 0.34 |
C Allele | 80 (38.3) | 1 | 203 (38.6) | 1 | 207 (36.8) | 1 | |||
T Allele | 126 (61.2) | 1.01 (0.73,1.41) | 0.95 | 323 (61.4) | 0.93 (0.73,1.86) | 0.55 | 355 (63.2) | 1.09 (0.78,1.51) | 0.61 |
The two-sided χ2 test or Fisher's exact test was used in the comparison of allele distributions.
CHB vs. LC
LC vs. HCC
CHB vs. HCC, adjusted for age, gender, smoking and alcohol consumption by logistic regression analysis. APOBEC3, apolipoprotein B mRNA-editing catalytic polypeptide-like 3; SNPs, single nucleotide polymorphisms; CHB, chronic hepatitis B; LC, liver cirrhosis; HCC, hepatocellular carcinoma; OR, odds ratio; CI, confidence intervals.